Related by context. All words. (Click for frequent words.) 73 chlamydial infection 70 pre cancerous lesions 70 precancerous cervical lesions 70 CIN3 70 vaginal lesions 70 endometrial hyperplasia 70 cervical intraepithelial neoplasia 69 CMV infection 69 CIN2 + 69 abnormal pap smears 69 nonmelanoma skin cancers 69 endometrial cancers 69 neoplasias 68 precancers 68 HPV infections 68 leiomyomas 68 basal cell carcinoma BCC 68 grade cervical intraepithelial 68 genital lesions 68 osteosarcomas 68 ASCUS 68 adenomatous polyps 68 endometrial carcinoma 68 prostate cancer CaP 68 genital herpes infections 68 precancerous cervical 67 pre malignant lesions 67 anal lesions 67 precursor lesions 67 anal cancers 67 HNSCC 67 HGPIN 66 basal cell nevus syndrome 66 malignant growths 66 external genital lesions 66 abnormal cytology 66 ano genital warts 66 differentiated thyroid 66 colorectal neoplasms 66 cervical carcinoma 66 advanced adenomas 66 CIN3 + 66 malignant lesions 66 colorectal adenoma 66 gastric adenocarcinoma 66 cervical vaginal 66 prostate adenocarcinoma 66 perimenopausal women 66 Chlamydia trachomatis infection 66 abnormal Pap smears 66 premalignant lesion 66 Prostatitis 66 genital ulcers 66 chlamydial infections 65 basal cell cancers 65 CIN2 65 acute GvHD 65 orchitis 65 cancerdefine 65 dysplastic lesions caused 65 colorectal tumors 65 nonmelanoma skin cancer 65 premalignant 65 testicular tumors 65 basal cell carcinomas 65 advanced adenoma 65 dysplastic lesions 65 cervical dysplasia 65 HER2 overexpression 65 HPV# 65 chronic periodontitis 65 invasive carcinoma 65 lichen planus 65 epithelial tumors 65 abnormal Pap tests 65 SLNB 65 lobular carcinoma 65 invasive cervical cancer 65 Chlamydia infection 65 intestinal polyps 65 precancerous lesions 65 cancerous cervical lesions 65 Candida infection 65 ductal breast cancer 64 VZV 64 PCNSL 64 inflammatory acne 64 neuroblastoma tumors 64 ovarian carcinoma 64 Adenomas 64 prostate cancers 64 cutaneous melanoma 64 superficial bladder cancer 64 Basal cell 64 cervical abnormalities 64 grade cervical dysplasia 64 precancerous tumors 64 contralateral breast 64 vaginal cancers 64 breast carcinoma 64 HPV infection 64 oesophageal adenocarcinoma 64 vulvar intraepithelial neoplasia 64 premalignant lesions 64 BRCA deficient 64 atypical hyperplasia 64 relapsed MM 64 GISTs 64 radioiodine therapy 64 grade gliomas 64 HbF 64 grade squamous intraepithelial 64 androgen deprivation 64 pre cancerous growths 64 CP CPPS 64 pre cancerous polyps 64 fibroadenomas 64 antiandrogens 64 colorectal cancer CRC 64 simplex virus 64 mucosal lesions 64 B7 H3 64 HER2 positive cancers 64 cisplatin resistant 64 lobular cancer 64 gonococcal infection 64 BRCA mutation carriers 64 bacterial vaginosis 64 choriocarcinoma 64 thyroid carcinoma 63 keratoses 63 chlamydial 63 PAP smear 63 gastrointestinal stromal tumors GIST 63 GnRH agonists 63 recurrent bladder 63 carotid stenosis 63 Androgen deprivation therapy 63 chronic prostatitis 63 lymph node removal 63 CMV infections 63 squamous cell cancers 63 N. gonorrhoeae 63 Adjuvant chemotherapy 63 cervical vulvar 63 onset diabetes mellitus 63 colorectal adenomas 63 abnormal Pap smear 63 malignant polyps 63 colorectal polyp 63 ADPKD 63 NNRTI resistance 63 endocrine tumors 63 pancreatic lung 63 HIV HCV coinfected 63 hepatitis C genotype 63 recurrent genital herpes 63 abnormal mammograms 63 polyp recurrence 63 transfusion syndrome 63 recurrent metastatic 63 recurrent glioblastoma multiforme 63 anal HPV 63 bladder cancers 63 atypical ductal hyperplasia 63 proliferative diabetic retinopathy 63 polycystic ovary syndrome PCOS 63 MGUS 63 epithelial ovarian 63 colorectal polyps 63 seminoma 63 anogenital warts 63 bowel polyps 63 epithelial ovarian cancer 63 recurrent UTI 63 overt hypothyroidism 63 HPV subtypes 63 herpes infection 63 adenoma 63 type 1diabetes 63 peritoneal carcinomatosis 63 Ovarian cysts 63 HPV-#/# 63 adjuvant radiotherapy 63 ductal cancer 63 metastatic lesions 63 situ CIS 63 Hurthle cell 63 coinfection 63 endometrial biopsies 63 HBV infections 63 EBV infection 63 operable breast cancer 63 Endometrial cancer 63 EBRT 63 squamous cell carcinoma SCC 63 skeletal metastases 63 invasive candidiasis 63 oncogenic HPV 63 herpes zoster vaccine 63 ovarian tumors 63 HBV infection 63 cutaneous squamous cell carcinoma 63 PCa 62 Heavy menstrual bleeding 62 thyroid nodules 62 abnormal Pap test 62 Sjögren syndrome 62 benign noncancerous 62 abnormal pap tests 62 verteporfin 62 bacteriuria 62 caspofungin 62 metastatic gastric 62 intravenous bisphosphonates 62 #.#ng/ml 62 malignant prostate 62 metastatic neuroendocrine tumors 62 specific antigen PSA 62 vulvar cancers 62 colorectal carcinoma 62 Squamous cell carcinomas 62 invasive cervical cancers 62 HBeAg negative 62 breast carcinomas 62 Trichomonas vaginalis 62 hypertrophic scars 62 urothelial carcinoma 62 detect precancerous lesions 62 undergoing radical prostatectomy 62 ocular toxicity 62 pharyngeal cancer 62 anal intraepithelial neoplasia 62 keloid 62 amenorrhoea 62 breast endometrial 62 latent tuberculosis infection 62 anaplastic 62 C. trachomatis 62 cranial irradiation 62 BCG vaccinated 62 cervical precancers 62 penile cancers 62 prostate cancer PCa 62 progesterone receptor negative 62 peritoneal cancer 62 IV bisphosphonates 62 venous blood clots 62 abnormal Pap 62 poorer prognosis 62 colonic polyps 62 Human papillomavirus 62 irregular menstrual cycles 62 AVODART 62 serum PSA 62 quadrivalent vaccine 62 pulmonary metastases 62 node metastases 62 corticosteroid therapy 62 serous ovarian cancer 62 Neisseria gonorrhoeae 62 breast lesions 62 Human papillomavirus HPV 62 nonproliferative 62 elevated CRP 62 latent tuberculosis TB 62 gallstone disease 62 cervical cancer genital warts 62 colorectal liver metastases 62 renal cell carcinomas 62 Radical prostatectomy 62 systemic scleroderma 62 Acute Myeloid Leukaemia AML 62 recurrent VTE 62 anterior uveitis 62 grade cervical lesions 62 thyroid deficiency 62 ovarian malignancy 62 arterial calcification 62 histologic subtype 62 dose ionizing radiation 62 CYT# potent vascular disrupting 62 SHBG levels 62 vesicoureteral reflux 62 polycystic ovarian syndrome PCOS 62 cervical neoplasia 62 testicular cancers 62 G6PD deficiency 62 benign breast 62 urethritis 62 placental malaria 62 candidemia 62 bladder carcinoma 62 HCV infection 62 genital ulcer disease 62 HER2 expression 62 BRCA1 mutation carriers 62 advanced neoplasia 62 papillomas 62 hematopoietic cancers 62 herpes zoster shingles 62 osteopenic 62 Squamous 62 squamous carcinoma 62 MYCN amplification 62 human papillomaviruses HPV 62 bullous 62 fluoroquinolone resistance 61 Opportunistic infections 61 genital wart 61 varicella infection 61 preventing genital warts 61 neurofibromas 61 biochemical relapse 61 allogeneic HSCT 61 ertapenem 61 Genital herpes 61 Cholangiocarcinoma 61 Squamous cell 61 PCA3 scores 61 hepatic fibrosis 61 neoplasia 61 pre eclamptic 61 recurrent venous thromboembolism 61 SGPT 61 Acute myeloid leukemia 61 Malignant Melanoma 61 Colon polyps 61 neoplasia PIN 61 rebleeding 61 thyroid dysfunction 61 nonhormonal 61 bone metastasis 61 papilloma 61 histological subtype 61 dexamethasone Decadron 61 Uterine fibroids 61 neutropenic 61 HPV types 61 LYSTEDA 61 incidentalomas 61 hormone deprivation 61 Pap smear screening 61 fallopian tube carcinoma 61 seminomas 61 penicillin allergy 61 gastric carcinoma 61 recurrent miscarriage 61 immunocompetent 61 abnormal vaginal bleeding 61 choroidal neovascularization 61 BRCA mutation 61 neoplastic lesions 61 lobular breast cancer 61 premenopausal breast cancer 61 malignant neoplasm 61 bilateral oophorectomy 61 severe rotavirus gastroenteritis 61 prostate specific 61 intraepithelial neoplasia 61 androgen suppression therapy 61 serum urate levels 61 ALA PDT 61 Carcinoid tumors 61 hypovitaminosis D 61 recurrent ovarian 61 somatostatin analogs 61 Basal Cell 61 Leydig cell 61 trichomonas 61 Melasma 61 prostatic hyperplasia 61 mucinous 61 clinically localized prostate 61 T1DM 61 trastuzumab Herceptin ® 61 Tindamax R 61 serum prostate 61 HPV 61 Hormonal therapy 61 KRAS mutations occur 61 BRCA mutations 61 Barrett esophagus BE 61 pre cancerous 61 tumoral 61 thrombotic complications 61 invasive lobular carcinoma 61 androgen ablation 61 colorectal neoplasia 61 Helicobacter pylori H. pylori 61 grade dysplasia 61 nucleotide analog 61 GIST tumors 61 invasive lobular 61 BRAF mutations 61 hormonally sensitive 61 benign prostatic hypertrophy 61 BRAF mutation 61 oral squamous cell 61 thromboembolic disease 61 subclinical disease 61 genital ulcer 61 vulvar vaginal 61 bowel cancers 61 postoperative infection 61 chromosomal mutations 61 leiomyoma 61 LTBI 61 ovulatory cycles 61 hormone refractory 61 periodontitis 61 estrogen progestin therapy 61 metaplasia 61 atrophic gastritis 61 S. aureus colonization 61 hormonal therapies 61 antigen PSA 61 Actinic Keratosis 61 malignant ascites 61 hemorrhagic complications 61 EXJADE 61 adenomatous 61 untreated celiac disease 61 histopathologic examination 61 antitumor effect 61 primary hyperparathyroidism 61 renal scarring 61 denser breasts 61 hamartomas 61 abnormal pap smear 61 invasive ductal 61 acne vulgaris 61 axillary lymph nodes 61 Synovial sarcoma 61 neutropenic patients 61 Genital warts 61 cancerous polyps 61 HER2 amplification 61 diabetes mellitus DM 61 induce ovulation 61 ALT flares 61 prostate cancer metastases 61 sonographic diagnosis 61 superficial basal cell carcinoma 60 squamous cell lung cancer 60 cytoreductive surgery 60 FluCAM arm 60 gynecologic malignancy 60 TMP SMX 60 reproductive tract infections 60 poliovirus vaccine 60 cytotoxic therapy 60 grade glioma 60 lymph node biopsies 60 hypothalamic amenorrhea 60 chlamydia trachomatis 60 coronary calcification 60 oropharyngeal cancer 60 aminotransferases 60 glucocorticoid induced osteoporosis 60 gastric cardia 60 antibody titer 60 pulmonary metastasis 60 hepatocellular cancer 60 BRAF V#E mutation 60 transferrin saturation 60 PCOD 60 uterine tumors 60 malignant neoplasms 60 oncogenic HPV types 60 hyperplastic polyps 60 malignancies 60 cancers 60 Anthracycline 60 Human Papilloma Virus 60 parasitemia 60 NNRTI resistant virus 60 neoplasm 60 recurrent UTIs 60 vulvar 60 H Pylori 60 prognostic indicator 60 impair fertility 60 nonmelanoma 60 transgenic rats 60 Recombinant interferon alpha 60 anti HBs 60 elevated triglyceride levels 60 Pneumocystis carinii pneumonia 60 varicella zoster virus VZV 60 neurologic deficits 60 ductal lobular 60 endometriosis ovarian cysts 60 nonalcoholic steatohepatitis NASH 60 Bacillus Calmette Guerin BCG 60 curable cancers 60 atopic asthma 60 mammographically 60 S. aureus infections 60 sentinel nodes 60 Epstein Barr virus EBV 60 cholangiocarcinoma 60 adenoma recurrence 60 periodontal bacteria 60 transaminase elevations 60 noscapine 60 PAP smears 60 mutated K ras 60 hepatitis B infection 60 VFEND 60 cancerous colon polyps 60 atrophic vaginitis 60 precancerous condition 60 nanomolar 60 tumor histology 60 wart virus 60 acute GVHD 60 carcinoid tumor 60 axillary node dissection 60 testicular germ cell 60 Candida infections 60 premenstrual syndrome PMS 60 sexually transmitted HPV 60 Haptoglobin 60 cervical lymph nodes 60 refractory ovarian cancer 60 solar keratoses 60 suppressive therapy 60 solar keratosis 60 nonvaccine serotypes 60 deep venous thromboses 60 Asymptomatic 60 vulvar lesions 60 proctitis 60 cytological 60 gonococcal infections 60 PSADT 60 squamous cell carcinomas 60 mammographic density 60 Candidiasis 60 GH deficiency 60 hypereosinophilic syndrome 60 bronchogenic carcinoma 60 ovarian hormones 60 LHRH agonists 60 gastrointestinal stromal tumors GISTs 60 serum IgE 60 BRCA1 mutations 60 proliferative retinopathy 60 molar pregnancy 60 cervical cytology 60 cytologic 60 Severe Primary IGFD 60 pre cancerous lesion 60 leukaemias 60 MALT lymphoma 60 prostate ovarian 60 Chlamydia infections 60 dexrazoxane 60 prednisone prednisolone 60 Chronic Prostatitis 60 acromegalic patients 60 tumors GIST 60 mutated KRAS gene 60 baseline LDH 60 chemopreventive agent 60 bacterial vaginosis BV 60 EGFR mutation 60 cervical HPV 60 oral leukoplakia 60 locoregional recurrence 60 Hepatocellular Carcinoma HCC 60 vulvovaginal atrophy 60 dysmenorrhoea 60 tumor subtypes 60 HBV vaccine 60 periodontal gum disease 60 precancer 60 neoplasms 60 recurrent glioma 60 neovascularisation 60 chronic GVHD 60 H pylori 60 chorioamnionitis 60 Adhibit 60 primary ovarian insufficiency 60 S. aureus isolates 60 fibroadenoma 60 urothelial bladder cancer 60 Benign prostatic hyperplasia BPH 60 metastatic bladder 60 imatinib therapy 60 ductal carcinomas 60 Papillary 60 Zolinza 60 renal tumors 60 relapsed ovarian cancer 60 beta blocker therapy 60 dopaminergic therapy 60 RAS mutations 60 CMV disease 60 antiestrogen 60 genital tract infections 60 herpetic 60 benign lesions 60 relapsing remitting MS RRMS 60 fibrocystic changes 60 penetrance 60 abnormal uterine bleeding 60 aromatase inhibitor therapy 60 estrogen receptor negative 60 benign polyps 60 pneumococcal infection 60 pelvic malignancies 60 aminotransferase levels 60 metachronous 60 anal incontinence 60 BRCA2 mutation carriers 60 endometrial tumors 60 herpes simplex encephalitis 60 HPV genotypes 60 invasive aspergillosis 60 immunological responses 60 nonmetastatic 60 acute leukemias 60 chronically immunosuppressed solid 60 abnormal pap 60 melasma 60 oropharyngeal cancers 59 human papilloma 59 urine cytology 59 lupus anticoagulant 59 hyperplastic 59 carcinoids 59 chronic hepatitis cirrhosis 59 P. falciparum malaria 59 Benign breast 59 intensive statin therapy 59 adjuvant radiation 59 methicillin susceptible Staphylococcus aureus 59 prostate tumors 59 adenomas 59 gastrointestinal stromal tumor GIST 59 bladder tumors 59 micronuclei 59 ovarian suppression 59 epididymitis 59 pediatric malignancies 59 spontaneously regress 59 Hematologic 59 HeFH 59 liver scarring 59 Dupuytren Disease 59 postoperative morbidity 59 PSA nadir 59 atherosclerotic lesions 59 adenomatous polyp 59 subclinical hypothyroidism 59 nonmalignant 59 pCR 59 NMIBC 59 chronic rhinosinusitis CRS 59 Mitomycin C 59 Cervista HPV HR 59 Staphylococcus aureus infections 59 imatinib Gleevec 59 often detect precancerous 59 hyperphenylalaninemia HPA due 59 glioblastoma tumor 59 resistant hormone refractory 59 nucleoside analogues 59 estrogen receptor ER 59 Leukemias 59 osteoporotic vertebral compression fractures 59 malignant lymphoma 59 renal carcinoma 59 breast cancers 59 malignant melanomas 59 Metastases 59 gestational hypertension 59 Prostate Specific Antigen PSA 59 forodesine 59 curative resection 59 acute aortic dissection 59 transrectal ultrasound guided 59 Human Papillomavirus 59 pelvic lymphadenectomy 59 androgen deficiency 59 chlamydia infection 59 tibolone 59 colorectal cancers 59 clinically detectable 59 Human papilloma virus 59 embryonal rhabdomyosarcoma 59 lung metastasis 59 colorectal cancer liver metastases 59 immunosuppressive therapies 59 thrombophilia 59 protease inhibitors PIs 59 cinacalcet 59 Kinoid 59 Basal cell carcinoma 59 vaginal flora 59 malignancy 59 leukemia ALL 59 Recurrences 59 HCV antibody 59 squamous intraepithelial lesions 59 HCV infections 59 chronic HCV 59 diabetic kidney 59 cytomegalovirus infection 59 artery stenosis 59 chronic HBV 59 excessive menstrual bleeding 59 posterior uveitis 59 azoospermia 59 serum homocysteine 59 melanomas 59 leukemia AML 59 metastatic prostate 59 HIV uninfected 59 urinary tract symptoms LUTS 59 tumor recurrence 59 MAGE A3 ASCI 59 pyrimethamine 59 liver fibrosis 59 nonsmall cell lung cancer 59 thiopurine 59 knee osteoarthritis OA 59 VUR 59 endometrial 59 invasive fungal infection 59 nonvaccine 59 hepatorenal syndrome 59 refractory prostate cancer 59 pulmonary dysfunction 59 axillary node 59 faulty BRCA genes 59 hyperplasia BPH 59 cervicitis 59 Bacille Calmette Guerin BCG 59 severe periodontitis 59 colonoscopy screenings 59 situ LCIS 59 unresectable tumors 59 artery embolization 59 BCR ABL mutations 59 hyperoxaluria 59 catheter angiography 59 myelodysplastic myeloproliferative diseases 59 Uterine cancer 59 immunopathology 59 diagnostic biomarker 59 flutamide 59 cisplatin chemotherapy 59 serum testosterone 59 urate levels 59 stratifying patients 59 endometrial ovarian 59 VivaGel TM 59 TT genotype 59 ovarian lung 59 histologically proven 59 invasive carcinomas 59 serologic testing 59 bacterium Neisseria meningitidis 59 HER2 positive tumors 59 fibrin deposition 59 cytoreduction 59 FISH fluorescence 59 nonseminoma 59 FSAD 59 nucleotide analogs 59 systemic lupus erythematosus SLE 59 immunosuppressed patients 59 Oral contraceptive 59 metastatic lymph nodes 59 lymph node dissection 59 thromboembolic complications 59 uterine fibroid 59 neutrophil counts 59 cranial radiation 59 urolithiasis 59 distant metastases 59 Alequel 59 IgM antibodies 59 HSV2 59 LHRH receptor positive 59 C1 INH deficiency 59 dysplasias 59 pathologic fractures 59 genotypic resistance 59 juvenile idiopathic arthritis 59 prostate cancer CRPC 59 antiviral therapy 59 enterovirus infection 59 antiangiogenic agents 59 neovascular 59 tamoxifen Nolvadex ® 59 invasive meningococcal disease 59 nasopharyngeal carcinoma 59 abacavir Ziagen 59 colorectal gastric 59 prolonged QT interval 59 postexposure prophylaxis 59 initiating HAART 59 candidiasis 59 postoperative pulmonary 59 fallopian tube cancers 59 pituitary adenomas 59 hydroxyvitamin D levels 59 varicocele 59 renal toxicity 59 vaginal yeast infections 59 B Cell Lymphoma 59 dasatinib Sprycel 59 benign nodules 59 aciclovir 59 AGHD 59 Toxicities 59 Oral contraceptives 59 indolent lymphomas 59 invasive breast cancer 59 carotid plaques 59 hypervascular tumors 59 relapsed ALL 59 hypercholesterolaemia 59 LHRH analogues 59 E selectin 59 Ophena TM 59 anti androgen 59 octreotide LAR 59 metastatic malignant 59 EGFRIs 59 ovarian endometrial 59 detecting precancerous 59 chlamydia infections 59 HIV seronegative 59 urethral stricture 59 repigmentation 59 Anaplastic 59 apocrine 59 HSV1 59 asymptomatic carotid stenosis 59 pancreatic adenocarcinoma 59 lymphadenopathy 59 prostate biopsies 59 onset puberty 59 GBM tumors 59 Rectal cancer 59 BRAF gene 59 low expressors 59 lymphoid tumors 59 gastric cancers 59 pneumococci 59 precancerous spots 59 intrauterine infection 59 colon adenomas 59 hereditary breast cancer 59 seronegative 59 mammary cancers 59 oesophageal squamous cell carcinoma 59 biochemical abnormalities 59 antiandrogen 59 irregular menses 59 keloid scars 59 polypoid 59 LNG IUS 59 esophageal cancers 59 papillary carcinoma 59 lipomas 59 minimally symptomatic metastatic castrate 59 induce remission 59 Natalizumab 59 progestagen 59 breast tumors 59 H. pylori eradication 59 carcinoid tumors 59 axillary dissection 59 intradermal injection 59 biochemical recurrence 59 indinavir 59 prostate carcinoma 59 PKC inhibitors 59 atopic disease 59 CaP 59 hyperbilirubinemia 59 metastatic malignant melanoma 59 castrate resistant prostate cancer 59 serum TSH 59 malignant lymphomas 59 dysplastic nevi 59 metronidazole gel 59 mIU ml 58 lumbar spinal stenosis LSS 58 CC genotype 58 nephrotoxicity 58 Estrogens 58 uveal melanoma 58 aneuploid cells 58 estrogen hormone therapy 58 glucocorticoid therapy 58 micafungin 58 spontaneous preterm birth 58 systemic toxicity 58 QuantiFERON 58 metastatic prostate cancer 58 liver metastasis 58 lymphomas leukemias 58 Glioblastoma Multiforme GBM 58 ribavirin therapy 58 chromosomal aberrations 58 enteroviral infection 58 Endometrial 58 hormone receptor negative 58 spontaneous preterm delivery 58 endocrine therapies 58 non metastatic osteosarcoma 58 urothelial cancer 58 AGILECT R 58 Enlarged prostate 58 AAT deficiency 58 nonmetastatic prostate cancer 58 thyroglobulin 58 secondary amenorrhea 58 Cytomegalovirus CMV 58 varices 58 preoperative chemotherapy 58 hematologic abnormalities 58 genital HPV infection 58 Inhibin B 58 cytomegalovirus infections 58 colon tumors 58 aortic atherosclerosis 58 Testicular cancer 58 erlotinib Tarceva ® 58 OAB symptoms 58 adrenalectomy 58 hematologic toxicity 58 prostate carcinogenesis 58 KRAS mutant tumors 58 mRCC 58 endometrial lining 58 Hilakivi Clarke 58 candida infections 58 vaginal hysterectomy 58 Statin therapy 58 papillary renal cell carcinoma 58 hyperalgesia 58 autoantibody positive 58 pemphigus vulgaris 58 antimicrobial prophylaxis 58 virological response 58 RhD negative 58 pharyngeal cancers 58 subclinical 58 squamous 58 pelvic inflammatory disease 58 overactive bladder symptoms 58 pT3 58 gastrointestinal stromal tumor 58 abnormal cervical 58 PAOD 58 FDG-PET/CT 58 squamous cell skin 58 Gleevec resistant 58 imatinib resistance 58 leukaemic stem cells 58 trimethoprim sulfamethoxazole 58 Candida species 58 taxane therapy 58 malignant nodules 58 anogenital 58 membranous nephropathy 58 prostate pancreatic 58 pre cancerous actinic 58 haematological cancers 58 keloids 58 HER2 positive breast cancer 58 Androgenetic Alopecia 58 breast abscesses 58 neoplasia CIN 58 de ath 58 lymphocytosis 58 antiplatelet medications 58 elevated LDH 58 abdominal adiposity 58 neuroendocrine carcinoma 58 HBsAg 58 NP CRNs 58 secondary hyperparathyroidism 58 ependymoma 58 vaccinees 58 NATRECOR ® 58 Chlamydia trachomatis 58 esophageal gastric 58 MGd 58 Thyroid nodules